Table 3 Multivariable-adjusted odds ratio and 95% confidence intervals for nonalcoholic fatty liver disease (NAFLD) according to tertiles of dietary patterns in all adult participants and stratified by sex, Amol Cohort Study, Iran, 2016–2017 (n 3220).

From: Favorable association between Mediterranean diet (MeD) and DASH with NAFLD among Iranian adults of the Amol Cohort Study (AmolCS)

 

DASH

MeD

Tertile 1

Tertile 2

Tertile 3

Ptrend

Tertile 1

Tertile 2

Tertile 3

Ptrend

NAFLD compared with non-NAFLD

Median score

25

28

31

 

2

4

5

 

NAFLD cases (N, %)

1386 (43)

981 (30.5)

853 (26.5)

 

1675 (52)

886 (27.5)

659 (20.5)

 

 Model 1

Ref

0.99 (CI 0.84–1.17)

0.81 (CI 0.68–0.96)

0.02

Ref

1.01 (CI 0.75–1.36)

0.63 (CI 0.45–0.90)

0.003

 Model 2

Ref

1.00 (CI 0.84–1.18)

0.79 (CI 0.66–0.94)

0.01

Ref

1.11 (CI 0.94–1.32)

0.65 (CI 0.53–0.79)

0.005

 Model 3

Ref

1.02 (CI 0.85–1.21)

0.80 (CI 0.66–0.96)

0.02

Ref

1.07 (CI 0.90–1.27)

0.64 (CI 0.52–0.78)

0.002

Women

Median score

26

28

31

 

2

4

5

 

NAFLD cases (N, %)

570 (39.6)

469 (32.6)

399 (27.7)

 

820 (57)

392 (27.3)

226 (15.7)

 

 Model 1

Ref

0.95 (CI 0.74–1.23)

0.73 (CI 0.56–0.95)

0.02

Ref

1.15 (CI 0.90–1.48)

0.65 (CI 0.33–0.65)

0.006

 Model 2

Ref

1.02 (CI 0.76–1.36)

0.71 (CI 0.52–0.97)

0.04

Ref

1.13 (CI 0.85–1.50)

0.43 (CI 0.30–0.63)

0.006

 Model 3

Ref

1.02 (CI 0.76–1.36)

0.72 (CI 0.53–0.98)

0.05

Ref

1.10 (CI 0.83–1.47)

0.42 (CI 0.29–0.61)

0.004

Men

Median score

25

29

31

 

2

4

5

 

NAFLD cases (N, %)

816 (45.8)

512 (28.7)

454 (25.5)

 

855 (48)

494 (27.7)

433 (24.3)

 

 Model 1

Ref

1.04 (CI 0.83–1.30)

0.93 (CI 0.74–1.18)

0.64

Ref

1.04 (CI 0.83–1.30)

0.77 (CI 0.61–0.98)

0.12

 Model 2

Ref

1.03 (CI 0.78–1.34)

0.89 (CI 0.67–1.19)

0.52

Ref

1.11 (CI 0.85–1.45)

0.72 (CI 0.54–0.95)

0.12

 Model 3

Ref

1.01 (CI 0.77–1.33)

0.88 (CI 0.66–1.17)

0.45

Ref

1.06 (CI 0.81–1.40)

0.70 (CI 0.53–0.94)

0.07

  1. DASH: Dietary Approaches to Stop Hypertension, MeD: Mediterranean diet, Ref: reference category.
  2. Model 1: adjusted for age and sex.
  3. Model 2: Additional adjustment for BMI, energy intake, physical activity, and smoking.
  4. Model 3: additional adjustment for Lowering serum lipid drugs, Lowering HPTN drugs, Lowering serum glucose drugs, residual areas, heart disease, diabetes.